EN
HI
Summary
As of 25 Sep, 2026, Unjha Formulations stock price is ₹31. During the trading session, the stock has moved between an intraday low of ₹31.00 and an intraday high of ₹31.99. Over the last 52 weeks, Unjha Formulations has traded between ₹17.52 and ₹36.38.
The stock has recorded a trading volume of 250 shares,. Its Average Traded Price (ATP) is ₹31.39, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 150 @ ₹31.00.
Unjha Formulations has an upper circuit limit of ₹32.02 and a lower circuit limit of ₹28.98. The total value traded stands at ₹7847.50, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Unjha Formulations also offers a dividend yield of 0%.
Unjha Formulations Share Price Chart
Unjha Formulations Share Key Metrics
Volume
250.00
Market Cap
13.67 CR
LTQ@LTP
150@31.00
ATP
31.39
Var Margin
100 %
Circuit Range
28.98-32.02
Delivery %
100 %
Value
7847.50
ASM/GSM
No
Market Lot
1
Unjha Formulations Resistance and Support
Pivot 31
Resistance
First Resistance
31.5
Second Resistance
32.5
Third Resistance
33
Support
First Support
30
Second Support
29.5
Third Support
28.5
Unjha Formulations Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 25 2026 | 31.99 | 31 | 1.64% | 31.99 | 31 |
| Thu Sep 24 2026 | 32 | 30.5 | -4.69% | 32 | 30.5 |
| Wed Sep 23 2026 | 32.5 | 32 | -1.54% | 32.5 | 32 |
Unjha Formulations Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-03 | Quarterly Results |
| 2026-05-18 | Audited Results |
| 2026-02-04 | Quarterly Results |
| 2025-11-10 | Quarterly Results |
| 2025-08-06 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-03-17 | Others |
| 2025-02-04 | Quarterly Results |
| 2024-11-08 | Quarterly Results |
| 2024-08-01 | Quarterly Results |
Unjha Formulations Management
| Name | Position |
|---|---|
| Jashodaben S Patel | Chairperson |
| Krutiben M Patel | Managing Director & Compliance Officer |
Unjha Formulations Similar Stocks
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Parmax Pharma Ltd.
136.40
0.00 (0.00%)
Colinz Laboratories Ltd.
73.33
-1.67 (2.23%)
Broach Lifecare Hospital Ltd.
15.50
0.00 (0.00%)
Starsource Multitrade Ltd.
79.65
3.79 (5.00%)
Hindustan Bio Sciences Ltd.
7.62
0.17 (2.28%)
Kobo Biotech Ltd.
3.90
-0.07 (1.76%)
Dolphin Medical Services Ltd.
6.30
0.00 (0.00%)
Aanjaay Industries Ltd.
19.20
0.07 (0.37%)
Unjha Formulations FAQs
The Buying Price of Unjha Formulations share is 31 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Unjha Formulations stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Unjha Formulations, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Unjha Formulations shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Unjha Formulations shares is 0. Useful to assess the stock's value relative to its book value.
To assess Unjha Formulations’s valuation compare Sector P/E, P/B which are 38.09 & 3.65 with sector averages, along with growth rates and financial metrics.
The Market Cap of Unjha Formulations is 13.67 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Unjha Formulations share price is 36.38 & 17.52. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Unjha Formulations belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in UNJHAFOR
